Skip to content

Evaluation of the efficacy and safety of needle-knife fistulotomy versus conventional cannulation method in ampullary tumor-a prospective, multicenter, randomized, controlled study

Evaluation of the efficacy and safety of needle-knife fistulotomy versus conventional cannulation method in in ampullary tumor-a prospective, multicenter, randomized, controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092372
Enrollment
Unknown
Registered
2024-11-14
Start date
2024-06-02
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ampullary tumor

Interventions

NKF group:needle-knife fistulotomy (NKF)
CCM group:conventional cannulation method (CCM)

Sponsors

Department of gatroenterology,The First Affiliated Hospital, Jiangxi Medical College, Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Those who require endoscopic retrograde cholangiopancreatography (ERCP) for ampullary tumors, e.g., in combination with cholangitis, symptomatic jaundice (itching), or prior to neoadjuvant chemotherapy; 2. Those who need palliative biliary drainage for inoperable ampullary tumors; 3. Those who are at high risk of surgical intervention or refuse to undergo surgical intervention; 4. Ampullary tumors with a raised portion (Figure 1), with the main body structure remaining, that have been evaluated by two experienced ERCP operators and unanimously determined to be suitable for needle-knife fistulotomy (NKF); 5. More than 18 years old; 6. Voluntary participation and informed consent.

Exclusion criteria

Exclusion criteria: 1. Complete destruction of the primary papilla, making it unsuitable for NKF (Figure 2); 2. Contraindications to ERCP (platelets less than 100 x 10^9/L, international normalized ratio greater than 1.5; severe cardiopulmonary disease, etc.); 3. Combined duodeno-papillary biliary fistula; 4. Reconstructive surgery of the digestive tract; 5. Inability to discontinue anticoagulants and antiplatelet agents; 6. Intellectual disability that prevents normal communication 7. Allergy to the contrast media under study; 8. Previous ERCP or EST; 9. Pregnancy or lactation; 10. Not fit for the study judged by the researchers.

Design outcomes

Primary

MeasureTime frame
rate of successful cannulation;

Secondary

MeasureTime frame
time of cannulation;time of operation;rate of difficult cannulation;Adverse event rates;incidence of bleeding;incidence of perforation;Incidence of cholangitis;incidence of cholecystitis;

Countries

China

Contacts

Public ContactJunbo Hong

Department of gatroenterology,The First Affiliated Hospital, Jiangxi Medical College, Nanchang University

doctorhjb@126.com+86 137 6704 2550

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026